The power of PROTAC® technology through partnerships
We are believers in the expansive power of our PROTAC technology - it can be applied broadly across a wide range of disease areas. Our goal is to expand the universe of druggable targets, and we are exploring ways to achieve that goal both on our own and with strategic partners.
Learn about our current partnerships
We are expanding the potential impact of PROTAC protein degraders for patients with our current partners, Genentech, Pfizer and Bayer, and exploring the application of PROTAC protein degraders to agriculture through Oerth Bio, our joint venture with Bayer.